Successful, we will reply to you quickly.

OK

Please select the quantity.

OK

Your message is being sent, please wait.

Close

test

Close

Send mail failed, please send again!

Close

Products are for research use only. Not for human use. We do not sell to patients.

Signaling Pathway

CPDA

HY-18685

CPDA

CPDA Chemical Structure

CPDA is a novel potent SHIP2 inhibitor that can effectively ameliorate insulin resistance in 3T3-L1 adipocytes.

Size Price Stock Quantity
Free sample   Apply now  
10 mM * 1 mL in DMSO $154 In-stock
5 mg $140 In-stock
10 mg $220 In-stock
50 mg $810 In-stock
100 mg $1200 In-stock
200 mg Get quote
500 mg Get quote
Size Price Stock Quantity
Free sample   Apply now  
10 mM * 1 mL in DMSO €151 In-stock
5 mg €137 In-stock
10 mg €216 In-stock
50 mg €794 In-stock
100 mg €1176 In-stock
200 mg Get quote
500 mg Get quote

* Please select Quantity before adding items.

Bulk Inquiry

Inquiry Information
Product name: CPDA
Cat. No.: HY-18685

CPDA Data Sheet

  • Network Version

    DataSheet

Related Compound Libraries

Biological Activity of CPDA

CPDA is a novel potent SHIP2 inhibitor that can effectively ameliorate insulin resistance in 3T3-L1 adipocytes.
Target: SHIP2
in vitro: CPDA was found to enhance insulin signaling.
in vivo: CPDA greatly improves abnormal glucose metabolism in diabetic animals. CPDA was also found to improve the abnormal glucose metabolism in db/db mice.

Protocol (Extracted from published papers and Only for reference)

More

Chemical Information

M.Wt 388.8 Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Formula C20H15ClF2N2O2
CAS No 1415834-63-7
Solvent & Solubility

10 mM in DMSO

Preparing Stock Solutions

1 mg 5 mg 10 mg
1 mM 2.5720 mL 12.8601 mL 25.7202 mL
5 mM 0.5144 mL 2.5720 mL 5.1440 mL
10 mM 0.2572 mL 1.2860 mL 2.5720 mL

References on CPDA

Inhibitor Kit

Related Src Products

  • 1-NM-PP1

    1NM-PP1(PP1 Analog II) is a cell-permeable PP1 analog that acts as a potent and selective inhibitor of mutant kinases over their wild-type progenitors(IC50=28 uM vSrc; 4.2 nM v-Src-as1 I338G).

  • A-770041

    A-770041 is selective and orally active Src-family Lck inhibitor; A-770041 is a 147 nM inhibitor of Lck (1 mM ATP) and is 300-fold selective against Fyn, the other Src family kinase involved in T-cell signaling.

  • AMG-47a

    AMG-47a is a potent inhibitor of Lck and T cell proliferation; exhibits anti-inflammatory activity (ED50 = 11 mg/kg) in the anti-CD3 induced production of IL-2 in mice.

  • AZM475271

    AZM475271 is a potent and selective Src kinase inhibitor with IC50 of 5 nM; no inhibitory activity on Flt3, KDR, Tie-2.

  • Bosutinib

    Bosutinib is Src family kinase inhibitor. Bosutinib inhibited migration of breast cancer cell lines with IC50 values of 0.1 to 0.3 umol/L.

  • KX1-004

    KX1-004 is a potent small molecule inhibitor of Src-PTK as a potential protective drug for NIHL.

  • Lck Inhibitor

    Lck Inhibitor is a new class of compounds that are potent inhibitors of Lck with an IC50 value of 7 nM.

  • MCB-613

    MCB-613 is a potent, pan steroid receptor coactivator (SRC) stimulator.

  • PD173955

    PD173955 is src family-selective tyrosine kinase inhibitor with IC50 of ~22 nM for Src, Yes and Abl kinase; less potent for FGFR(alpha) and no activity on InsR and PKC.

  • PP1

    PP1(AGL 1872) is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.

MORE